Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inverse psoriasis in patient treated with atezolizumab.
Corneli P, di Meo N, Fagotti S, Conforti C, Farinazzo E, Zacchi A, Retrosi C, Vezzoni R, Pizzichetta MA, Zalaudek I. Corneli P, et al. Among authors: retrosi c. Int J Dermatol. 2020 Sep;59(9):e331-e332. doi: 10.1111/ijd.14876. Epub 2020 Apr 28. Int J Dermatol. 2020. PMID: 32346858 Free article. No abstract available.
Nivolumab-associated extragenital lichen sclerosus et atrophicus.
di Meo N, Conforti C, Corneli P, Vezzoni R, Retrosi C, Pizzichetta MA, Rizzi GM, Zalaudek I. di Meo N, et al. Among authors: retrosi c. Clin Exp Dermatol. 2020 Apr;45(3):350-352. doi: 10.1111/ced.14092. Epub 2019 Oct 11. Clin Exp Dermatol. 2020. PMID: 31498907 Free article. No abstract available.
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.
Zalaudek I, Corneli P, Vernoni S, Fedele D, Papa G, Conforti C, Retrosi C, Vezzoni R, Fagotti S, Longone M, Farinazzo E, di Meo N, Pizzichetta MA. Zalaudek I, et al. Among authors: retrosi c. Dermatol Ther. 2019 Nov;32(6):e13107. doi: 10.1111/dth.13107. Epub 2019 Oct 21. Dermatol Ther. 2019. PMID: 31595596 No abstract available.
Pattern of response of unresectable and metastatic cutaneous squamous cell carcinoma to programmed death-1 inhibitors: A review of the literature.
Corneli P, Conforti C, Retrosi C, Vezzoni R, di Meo N, Piccolo V, Farinazzo E, Russo T, Magaton Rizzi G, Giuffrida R, Zalaudek I. Corneli P, et al. Among authors: retrosi c. Dermatol Ther. 2020 Mar;33(2):e13250. doi: 10.1111/dth.13250. Epub 2020 Feb 20. Dermatol Ther. 2020. PMID: 32022968 Free article. Review.
Basal cell carcinomas are not only UV-related.
DI Meo N, Conforti C, Vezzoni R, Retrosi C, Longone M, Fadel M, Zalaudek I. DI Meo N, et al. Among authors: retrosi c. Ital J Dermatol Venerol. 2021 Dec;156(Suppl. 1 to No. 6):57-59. doi: 10.23736/S2784-8671.20.06357-9. Epub 2020 Feb 5. Ital J Dermatol Venerol. 2021. PMID: 32041935 Free article. No abstract available.
Secukinumab-induced subacute cutaneous lupus erythematosus.
Conforti C, Retrosi C, Giuffrida R, Vezzoni R, Currado D, Navarini L, Farinazzo E, Dell'Aquila C, Nan K, Di Meo N, Zalaudek I. Conforti C, et al. Among authors: retrosi c. Dermatol Ther. 2020 May;33(3):e13417. doi: 10.1111/dth.13417. Epub 2020 May 3. Dermatol Ther. 2020. PMID: 32291870 Free article. No abstract available.
What makes an inflammatory disease inflammatory? An overview of inflammatory mechanisms of allergic contact dermatitis, atopic dermatitis and psoriasis.
Farinazzo E, Giuffrida R, Dianzani C, Vezzoni R, Retrosi C, Zalaudek I, Conforti C. Farinazzo E, et al. Among authors: retrosi c. G Ital Dermatol Venereol. 2020 Dec;155(6):719-723. doi: 10.23736/S0392-0488.20.06551-7. Epub 2020 Apr 29. G Ital Dermatol Venereol. 2020. PMID: 32348082 Free article. Review.
29 results